Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-26-039856
Filing Date
2026-04-06
Accepted
2026-04-06 13:27:35
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8114
  Complete submission text file 0001104659-26-039856.txt   10045
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Subject) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SCHEDULE 13G | Act: 34 | File No.: 005-86817 | Film No.: 26840376
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 211 EAST 43RD STREET, SUITE 402 NEW YORK NY 10017
Business Address 211 EAST 43RD STREET, SUITE 402 NEW YORK NY 10017 646-278-6785
Esousa Group Holdings LLC (Filed by) CIK: 0002033034 (see all company filings)

EIN.: 881214533 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13G